Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066-Reference-Cited by-同舟云学术

Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066

Published:2018-05-08 Issue: Volume: Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Cheng Cong-Cong¹,Shi Li-Hong¹,Wang Xue-Jian¹,Wang Shu-Xiao²,Wan Xiao-Qing¹,Liu Shu-Rong¹,Wang Yi-Fei¹,Lu Zhong¹,Wang Li-Hua¹,Ding Yi¹

Affiliation:

1. Laboratory of Molecular Oncology, Weifang Medical College, Weifang, Shandong 261053, P.R. China

2. Department of Pharmacology, Weifang Medical College, Weifang, Shandong 261053, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous exposure to doxorubicin induces stem cell-like characteristics and plasticity in MDA-MB-231 breast cancer cells identified with the SORE6 reporter;Cancer Chemotherapy and Pharmacology;2024-08-24

2. Cancer stem cells: advances in knowledge and implications for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-05

3. Effects of CD44 siRNA on inhibition, survival, and apoptosis of breast cancer cell lines (MDA-MB-231 and 4T1);Molecular Biology Reports;2024-05-10

4. Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer;Frontiers in Oncology;2024-04-18

5. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery;Journal of Experimental & Clinical Cancer Research;2024-01-20